These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
895 related items for PubMed ID: 9462625
1. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study. Bergquist A, Glaumann H, Persson B, Broomé U. Hepatology; 1998 Feb; 27(2):311-6. PubMed ID: 9462625 [Abstract] [Full Text] [Related]
2. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence. Lewis JT, Talwalkar JA, Rosen CB, Smyrk TC, Abraham SC. Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079 [Abstract] [Full Text] [Related]
3. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma. Lewis JT, Talwalkar JA, Rosen CB, Smyrk TC, Abraham SC. Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228 [Abstract] [Full Text] [Related]
4. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study. Chalasani N, Baluyut A, Ismail A, Zaman A, Sood G, Ghalib R, McCashland TM, Reddy KR, Zervos X, Anbari MA, Hoen H. Hepatology; 2000 Jan; 31(1):7-11. PubMed ID: 10613720 [Abstract] [Full Text] [Related]
5. Characterization and clinical course of hepatobiliary carcinoma in patients with primary sclerosing cholangitis. Tischendorf JJ, Meier PN, Strassburg CP, Klempnauer J, Hecker H, Manns MP, Krüger M. Scand J Gastroenterol; 2006 Oct; 41(10):1227-34. PubMed ID: 16990210 [Abstract] [Full Text] [Related]
6. Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy. Brandsaeter B, Isoniemi H, Broomé U, Olausson M, Bäckman L, Hansen B, Schrumpf E, Oksanen A, Ericzon BG, Höckerstedt K, Mäkisalo H, Kirkegaard P, Friman S, Bjøro K. J Hepatol; 2004 May; 40(5):815-22. PubMed ID: 15094230 [Abstract] [Full Text] [Related]
7. Cholangiocarcinoma in young individuals with and without primary sclerosing cholangitis. Björnsson E, Angulo P. Am J Gastroenterol; 2007 Aug; 102(8):1677-82. PubMed ID: 17433022 [Abstract] [Full Text] [Related]
8. Characteristics and clinical course of primary sclerosing cholangitis in France: a prospective cohort study. Garioud A, Seksik P, Chrétien Y, Corphechot C, Poupon R, Poupon RE, Chazouillères O. Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):842-7. PubMed ID: 19779305 [Abstract] [Full Text] [Related]
9. Surgical outcome in patients with primary sclerosing cholangitis undergoing ileal pouch-anal anastomosis: a case-control study. Gorgun E, Remzi FH, Manilich E, Preen M, Shen B, Fazio VW. Surgery; 2005 Oct; 138(4):631-7; discussion 637-9. PubMed ID: 16269291 [Abstract] [Full Text] [Related]
10. Changes over a 20-year period in the clinical presentation of primary sclerosing cholangitis in Sweden. Bergquist A, Said K, Broomé U. Scand J Gastroenterol; 2007 Jan; 42(1):88-93. PubMed ID: 17190768 [Abstract] [Full Text] [Related]
11. Primary sclerosing cholangitis and malignancy. Boberg KM, Lind GE. Best Pract Res Clin Gastroenterol; 2011 Dec; 25(6):753-64. PubMed ID: 22117640 [Abstract] [Full Text] [Related]
12. High lifetime risk of cancer in primary sclerosing cholangitis. Claessen MM, Vleggaar FP, Tytgat KM, Siersema PD, van Buuren HR. J Hepatol; 2009 Jan; 50(1):158-64. PubMed ID: 19012991 [Abstract] [Full Text] [Related]
13. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis. Vera A, Gunson BK, Ussatoff V, Nightingale P, Candinas D, Radley S, Mayer A, Buckels JA, McMaster P, Neuberger J, Mirza DF. Transplantation; 2003 Jun 27; 75(12):1983-8. PubMed ID: 12829898 [Abstract] [Full Text] [Related]
15. Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis. Bergquist A, Broomé U. Best Pract Res Clin Gastroenterol; 2001 Aug 27; 15(4):643-56. PubMed ID: 11492973 [Abstract] [Full Text] [Related]
16. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis. Boberg KM, Jebsen P, Clausen OP, Foss A, Aabakken L, Schrumpf E. J Hepatol; 2006 Oct 27; 45(4):568-74. PubMed ID: 16879890 [Abstract] [Full Text] [Related]
17. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma. Kim KH, Lee SG, Park EH, Hwang S, Ahn CS, Moon DB, Ha TY, Song GW, Jung DH, Kim KM, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ. Ann Surg Oncol; 2009 Mar 27; 16(3):623-9. PubMed ID: 19130133 [Abstract] [Full Text] [Related]
18. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Burak K, Angulo P, Pasha TM, Egan K, Petz J, Lindor KD. Am J Gastroenterol; 2004 Mar 27; 99(3):523-6. PubMed ID: 15056096 [Abstract] [Full Text] [Related]
19. Two distinct pathways of carcinogenesis in primary sclerosing cholangitis. Zen Y, Quaglia A, Heaton N, Rela M, Portmann B. Histopathology; 2011 Dec 27; 59(6):1100-10. PubMed ID: 22175890 [Abstract] [Full Text] [Related]
20. Outcome and prognostic factors of 391 Japanese patients with primary sclerosing cholangitis. Tanaka A, Takamori Y, Toda G, Ohnishi S, Takikawa H. Liver Int; 2008 Aug 27; 28(7):983-9. PubMed ID: 18397233 [Abstract] [Full Text] [Related] Page: [Next] [New Search]